Veracyte Inc logo

VCYT - Veracyte Inc News Story

$47.51 0.6  1.3%

Last Trade - 05/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.30bn
Enterprise Value £2.05bn
Revenue £84.9m
Position in Universe 1764th / 6651

BRIEF-Veracyte Announces New Data Published In Journal Of Clinical Oncology Suggest The Prosigna Breast Cancer Test’S Genomic Underpinning Drives Prognostic Performance

Fri 30th October, 2020 3:06pm
Oct 30 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES NEW DATA PUBLISHED IN JOURNAL OF
CLINICAL
ONCOLOGY SUGGEST THE PROSIGNA BREAST CANCER TEST’S GENOMIC
UNDERPINNING DRIVES PROGNOSTIC PERFORMANCE

Source text for Eikon:  ID:nBw14qtvwa 
Further company coverage:  VCYT.O 

 ((Reuters.briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.